Copyright Reports & Markets. All rights reserved.

Global Point-of-care Testing (POCT) for Tumor Marker Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Based on Immunochromatography
    • 1.3.3 Based on Chemiluminescence Technology
    • 1.3.4 Based on Biosensor
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 lndependent Testing Organization
  • 1.5 Global Point-of-care Testing (POCT) for Tumor Marker Market Size & Forecast
    • 1.5.1 Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity (2021-2032)
    • 1.5.3 Global Point-of-care Testing (POCT) for Tumor Marker Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.1.4 Roche Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments/Updates
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.2.4 Abbott Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abbott Recent Developments/Updates
  • 2.3 BioMerieux
    • 2.3.1 BioMerieux Details
    • 2.3.2 BioMerieux Major Business
    • 2.3.3 BioMerieux Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.3.4 BioMerieux Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 BioMerieux Recent Developments/Updates
  • 2.4 Wondfo Biotech
    • 2.4.1 Wondfo Biotech Details
    • 2.4.2 Wondfo Biotech Major Business
    • 2.4.3 Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.4.4 Wondfo Biotech Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Wondfo Biotech Recent Developments/Updates
  • 2.5 Yuwell
    • 2.5.1 Yuwell Details
    • 2.5.2 Yuwell Major Business
    • 2.5.3 Yuwell Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.5.4 Yuwell Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Yuwell Recent Developments/Updates
  • 2.6 Getein Biotech
    • 2.6.1 Getein Biotech Details
    • 2.6.2 Getein Biotech Major Business
    • 2.6.3 Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.6.4 Getein Biotech Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Getein Biotech Recent Developments/Updates
  • 2.7 Beijing Wantai BioPharm
    • 2.7.1 Beijing Wantai BioPharm Details
    • 2.7.2 Beijing Wantai BioPharm Major Business
    • 2.7.3 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.7.4 Beijing Wantai BioPharm Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Beijing Wantai BioPharm Recent Developments/Updates
  • 2.8 Assure Tech
    • 2.8.1 Assure Tech Details
    • 2.8.2 Assure Tech Major Business
    • 2.8.3 Assure Tech Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.8.4 Assure Tech Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Assure Tech Recent Developments/Updates
  • 2.9 Randox
    • 2.9.1 Randox Details
    • 2.9.2 Randox Major Business
    • 2.9.3 Randox Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.9.4 Randox Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Randox Recent Developments/Updates
  • 2.10 Orient Gene
    • 2.10.1 Orient Gene Details
    • 2.10.2 Orient Gene Major Business
    • 2.10.3 Orient Gene Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.10.4 Orient Gene Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Orient Gene Recent Developments/Updates
  • 2.11 Hangzhou Biotest
    • 2.11.1 Hangzhou Biotest Details
    • 2.11.2 Hangzhou Biotest Major Business
    • 2.11.3 Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.11.4 Hangzhou Biotest Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hangzhou Biotest Recent Developments/Updates
  • 2.12 Shenzhen YHLO
    • 2.12.1 Shenzhen YHLO Details
    • 2.12.2 Shenzhen YHLO Major Business
    • 2.12.3 Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.12.4 Shenzhen YHLO Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Shenzhen YHLO Recent Developments/Updates
  • 2.13 Qingdao Hightop Biotech Co., Ltd.
    • 2.13.1 Qingdao Hightop Biotech Co., Ltd. Details
    • 2.13.2 Qingdao Hightop Biotech Co., Ltd. Major Business
    • 2.13.3 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.13.4 Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
  • 2.14 Getein Biotech, Inc.
    • 2.14.1 Getein Biotech, Inc. Details
    • 2.14.2 Getein Biotech, Inc. Major Business
    • 2.14.3 Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.14.4 Getein Biotech, Inc. Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Getein Biotech, Inc. Recent Developments/Updates
  • 2.15 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
    • 2.15.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Details
    • 2.15.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
    • 2.15.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Product and Services
    • 2.15.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Tumor Marker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates

3 Competitive Environment: Point-of-care Testing (POCT) for Tumor Marker by Manufacturer

  • 3.1 Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Point-of-care Testing (POCT) for Tumor Marker Revenue by Manufacturer (2021-2026)
  • 3.3 Global Point-of-care Testing (POCT) for Tumor Marker Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Tumor Marker by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Point-of-care Testing (POCT) for Tumor Marker Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Point-of-care Testing (POCT) for Tumor Marker Manufacturer Market Share in 2025
  • 3.5 Point-of-care Testing (POCT) for Tumor Marker Market: Overall Company Footprint Analysis
    • 3.5.1 Point-of-care Testing (POCT) for Tumor Marker Market: Region Footprint
    • 3.5.2 Point-of-care Testing (POCT) for Tumor Marker Market: Company Product Type Footprint
    • 3.5.3 Point-of-care Testing (POCT) for Tumor Marker Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Point-of-care Testing (POCT) for Tumor Marker Market Size by Region
    • 4.1.1 Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value by Region (2021-2032)
    • 4.1.3 Global Point-of-care Testing (POCT) for Tumor Marker Average Price by Region (2021-2032)
  • 4.2 North America Point-of-care Testing (POCT) for Tumor Marker Consumption Value (2021-2032)
  • 4.3 Europe Point-of-care Testing (POCT) for Tumor Marker Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Point-of-care Testing (POCT) for Tumor Marker Consumption Value (2021-2032)
  • 4.5 South America Point-of-care Testing (POCT) for Tumor Marker Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Point-of-care Testing (POCT) for Tumor Marker Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Type (2021-2032)
  • 5.2 Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value by Type (2021-2032)
  • 5.3 Global Point-of-care Testing (POCT) for Tumor Marker Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Application (2021-2032)
  • 6.2 Global Point-of-care Testing (POCT) for Tumor Marker Consumption Value by Application (2021-2032)
  • 6.3 Global Point-of-care Testing (POCT) for Tumor Marker Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Type (2021-2032)
  • 7.2 North America Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Application (2021-2032)
  • 7.3 North America Point-of-care Testing (POCT) for Tumor Marker Market Size by Country
    • 7.3.1 North America Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Point-of-care Testing (POCT) for Tumor Marker Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Type (2021-2032)
  • 8.2 Europe Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Application (2021-2032)
  • 8.3 Europe Point-of-care Testing (POCT) for Tumor Marker Market Size by Country
    • 8.3.1 Europe Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Point-of-care Testing (POCT) for Tumor Marker Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Point-of-care Testing (POCT) for Tumor Marker Market Size by Region
    • 9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Tumor Marker Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Type (2021-2032)
  • 10.2 South America Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Application (2021-2032)
  • 10.3 South America Point-of-care Testing (POCT) for Tumor Marker Market Size by Country
    • 10.3.1 South America Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Point-of-care Testing (POCT) for Tumor Marker Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Point-of-care Testing (POCT) for Tumor Marker Market Size by Country
    • 11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Tumor Marker Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Tumor Marker Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Point-of-care Testing (POCT) for Tumor Marker Market Drivers
  • 12.2 Point-of-care Testing (POCT) for Tumor Marker Market Restraints
  • 12.3 Point-of-care Testing (POCT) for Tumor Marker Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Point-of-care Testing (POCT) for Tumor Marker and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Tumor Marker
  • 13.3 Point-of-care Testing (POCT) for Tumor Marker Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Point-of-care Testing (POCT) for Tumor Marker Typical Distributors
  • 14.3 Point-of-care Testing (POCT) for Tumor Marker Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Tumor Marker market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Point-of-care Testing (POCT) for Tumor Marker market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Point-of-care Testing (POCT) for Tumor Marker market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Point-of-care Testing (POCT) for Tumor Marker market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Point-of-care Testing (POCT) for Tumor Marker market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Point-of-care Testing (POCT) for Tumor Marker market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Point-of-care Testing (POCT) for Tumor Marker
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Point-of-care Testing (POCT) for Tumor Marker market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, BioMerieux, Wondfo Biotech, Yuwell, Getein Biotech, Beijing Wantai BioPharm, Assure Tech, Randox, Orient Gene, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Point-of-care Testing (POCT) for Tumor Marker market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Based on Immunochromatography
    Based on Chemiluminescence Technology
    Based on Biosensor
    Others
    Market segment by Application
    Hospital
    lndependent Testing Organization
    Major players covered
    Roche
    Abbott
    BioMerieux
    Wondfo Biotech
    Yuwell
    Getein Biotech
    Beijing Wantai BioPharm
    Assure Tech
    Randox
    Orient Gene
    Hangzhou Biotest
    Shenzhen YHLO
    Qingdao Hightop Biotech Co., Ltd.
    Getein Biotech, Inc.
    Wuhan Easy Diagnosis Biomedicine Co.,ltd.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Point-of-care Testing (POCT) for Tumor Marker product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Tumor Marker, with price, sales quantity, revenue, and global market share of Point-of-care Testing (POCT) for Tumor Marker from 2021 to 2026.
    Chapter 3, the Point-of-care Testing (POCT) for Tumor Marker competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Point-of-care Testing (POCT) for Tumor Marker breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Point-of-care Testing (POCT) for Tumor Marker market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Tumor Marker.
    Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Tumor Marker sales channel, distributors, customers, research findings and conclusion.

    Buy now